PRESS RELEASE published on 10/23/2025 at 18:00, 5 months 3 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing. The company specializes in acquiring stakes in European pharmaceutical subcontractors Transparency Notification Shareholding Threshold Oxurion NV Belgian Transparency Legislation European Pharmaceutical Subcontractors
BRIEF published on 10/17/2025 at 18:05, 5 months 9 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Actions Transparency Notification Atlas Special Opportunities Oxurion
PRESS RELEASE published on 10/17/2025 at 18:00, 5 months 9 days ago Oxurion Receives Amended Transparency Notifications from Atlas Special Opportunities II LLC Oxurion receives amended transparency notifications from Atlas Special Opportunities II LLC regarding changes in shareholding thresholds, impacting voting securities Oxurion Shareholding Thresholds Transparency Notifications Voting Securities Atlas Special Opportunities II LLC
BRIEF published on 10/16/2025 at 18:05, 5 months 10 days ago Oxurion Notifies Changes in Participation of Atlas Special Opportunities II LLC Transparency Sale Of Shares Atlas Special Opportunities BUY Oxurion
PRESS RELEASE published on 10/16/2025 at 18:00, 5 months 10 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV receives transparency notifications regarding shareholding thresholds from Atlas Special Opportunities II, LLC as per Belgian Transparency legislation Oxurion NV Shareholding Thresholds Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC
BRIEF published on 10/15/2025 at 18:05, 5 months 11 days ago Oxurion Announces Update on Voting Rights After Convertible Bonds Conversion Voting Rights Convertible Bonds Capital Increase Shares Issued Oxurion
PRESS RELEASE published on 10/15/2025 at 18:00, 5 months 11 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion leading to EUR 100,000 capital increase. Oxurion issues 6,230,425 new ordinary shares as part of the Capital Commitment with Atlas Special Opportunities, LLC Convertible Bonds Capital Increase Share Issuance Atlas Special Opportunities Oxurion
BRIEF published on 10/13/2025 at 18:35, 5 months 13 days ago Oxurion considers acquiring a CRO to strengthen its strategy Clinical Development Oxurion Integration Strategy Axiodis CRO Acquisition
PRESS RELEASE published on 10/13/2025 at 18:30, 5 months 13 days ago Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis Oxurion NV announces the signing of a letter of intent to acquire a majority stake in a French Contract Research Organization (CRO) specialized in clinical development and regulatory affairs, enhancing its capabilities and services Acquisition Clinical Research Letter Of Intent Oxurion NV French CRO
BRIEF published on 10/09/2025 at 18:05, 5 months 17 days ago Oxurion Awaits Completion of Digital Asset Investment Investment Strategy Digital Assets Oxurion NV Bitcoin And Ethereum KYC/AML Procedures
Published on 03/27/2026 at 15:35, 13 minutes ago SouthGobi Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Published on 03/27/2026 at 12:30, 3 hours 18 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 3 hours 48 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 4 hours 48 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 15:05, 43 minutes ago Huawei's 6th Global Installer Summit: Gathering the Best Installers to Embrace Renewable Energy Opportunities in the AI Era
Published on 03/27/2026 at 14:31, 1 hour 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 03/27/2026 at 14:30, 1 hour 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 03/27/2026 at 14:29, 1 hour 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: AEW UK REIT plc
Published on 03/26/2026 at 18:17, 21 hours 31 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 07:30, 1 day 8 hours ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY